Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

ClinicalTrials.gov ID: NCT02135029

Public ClinicalTrials.gov record NCT02135029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 8:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Double-dummy, Randomized, Placebo And Active Controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Dyslipidemia Who Are Intolerant To Statins

Study identification

NCT ID
NCT02135029
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
184 participants

Conditions and interventions

Conditions

Interventions

  • Bococizumab (PF-04950615;RN316) Drug
  • Atorvastatin Drug
  • Placebo for Bococizumab (PF-04950615;RN316) Other
  • Placebo for atorvastatin Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Oct 31, 2015
Completion
Oct 31, 2015
Last update posted
Dec 13, 2017

2014 – 2015

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Creekside Endocrine Associates, PC Denver Colorado 80209
Bridgeport Hospital Bridgeport Connecticut 06610
Watson Clinic Center for Research, Inc. (for Drug Shipment only) Lakeland Florida 33805
Cardiovascular Research Center Of South Florida Miami Florida 33173
St. Johns Center for Clinical Research Ponte Vedra Florida 32081
Progressive Medical Research Port Orange Florida 32127
East-West Medical Research Institute Honolulu Hawaii 96814
NorthShore University HealthSystem - Evanston Hospital Evanston Illinois 60201
Health Care Centers of Illinois Mokena Medical Commons Mokena Illinois 60448
Advocate Medical Group Cardiology Normal Illinois 61761
Advocate Medical Group Midwest Heart Specialists Park Ridge Illinois 60068
Prairie Education & Research Cooperative (Administrative) Springfield Illinois 62701
Prairie Heart Institute Springfield Illinois 62701
St. John's Hospital Springfield Illinois 62769
The University of Iowa - College of Public Health - Preventive Intervention Center Iowa City Iowa 52242
The Iowa Clinic, PC West Des Moines Iowa 50266
University of Kansas Medical Center Kansas City Kansas 66160
Crescent City Clinical Research Center Metairie Louisiana 70006
Allina Health System, dba Abbott Northwestern Hospital Minneapolis Minnesota 55407
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Dayton Heart Center Dayton Ohio 45414
Clinical and Translational Research Center, Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104
Berks Cardiologists, Ltd. Wyomissing Pennsylvania 19610
PMG Research of Bristol Bristol Tennessee 37620
PMG Research of Knoxville, LLC Knoxville Tennessee 37912
San Antonio Military Medical Center Fort Sam Houston Texas 78234-6200
Office of Michelle Zaniewski MD., PA. Houston Texas 77090
Utah Cardiology, P.C. Layton Utah 84041
Aspen Clinical Research LLC Orem Utah 84058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02135029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02135029 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →